3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
27
Prostatic Hyperplasia
2
Urinary Incontinence
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Recurrence
1
Postoperative Complications
1
Lymphocele
1
Infertility
1
Disease
1
Adenocarcinoma
1
Interventions
Blood Specimen Collection
3
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
3
Surveys and Questionnaires
2
Prednisone
2
Positron-Emission Tomography
2
Magnetic Resonance Imaging
2
Injections
2
vistusertib
1
technetium 99m 1-(1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)-2-((1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)methyl)-9,14-dioxo-2,8,13,15-tetraazaoctadecane-7,12,16,18-tetracarboxylic acid)
1
pembrolizumab
1
lortalamine
1
ioflupane
1
gossypol acetic acid
1
carbon-11 acetate
1
abiraterone
1
Waiting Lists
1
Urine Specimen Collection
1
Urination
1
Transcutaneous Electric Nerve Stimulation
1
Therapeutics
1
Specimen Handling
1
Referral and Consultation
1
Prostatectomy
1
Preoperative Exercise
1
Positron Emission Tomography Computed Tomography
1
Pluvicto
1
Observation
1
Music Therapy
1
Multiparametric Magnetic Resonance Imaging
1
Mitomycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
Prostatectomy
×
Genitourinary
×
Clear all
NCT07054346
2026-04-01
LUTACT
University of California, San Francisco
Phase 1
Recruiting
45 enrolled